Investor Relations

Cadeler to Redomicile to the UK

September 21, 2026 • 4:30 PM ET

Cadeler plc has successfully closed its voluntary offer to exchange one share in Cadeler plc for each outstanding share of Cadeler A/S (including shares represented by American Depositary Shares). As a consequence, Cadeler is expected to complete its redomiciliation from Denmark to the United Kingdom, with shares in Cadeler plc expected to commence trading on both the OSE and NYSE on Thursday 5 November 2026.

Learn More

Latest News

View All News
View All News

Latest Presentation

H1 2026 Interim Financial Report - Investor Presentation
View All Presentations

Upcoming Event

Q3 2026 Earnings Release Presentation

Add to Calendar View All Events

Latest Financial Results

2026 H1

Quarter Ended Jun 30, 2026

View All Financial Results

Latest Annual Report

For Fiscal Year Ending Dec 31, 2025

View Annual Report View 20-F

Company Overview

Cadeler A/S (Cadeler) is a pure-play offshore wind installation partner and a global leader in offshore wind turbine transport and installation. The company owns and operates the industry’s largest fleet of jack-up offshore wind installation vessels and is expanding its capabilities into full-scope foundation transport and installation, as well as operations & maintenance. With its modern fleet and depth of expertise across onshore and offshore operations, Cadeler supports the safe, efficient and reliable delivery of offshore wind projects worldwide. Cadeler is listed on the New York Stock Exchange (ticker: CDLR) and the Oslo Stock Exchange (ticker: CADLR).

View Executive Team View Board of Directors

IR Contacts

Headquarters

Cadeler A/S
Kalvebod Brygge 43
Copenhagen V DK-1560
Denmark

Investor Relations

investorrelations@cadeler.com


Alexander Simmonds
EVP & CLO, Cadeler
T: +44 7376 174172
alexander.simmonds@cadeler.com

Transfer Agent

DNB Bank ASA, Registrar’s Department
P.O. Box 1600 Sentrum
0021 Oslo, Norway
T: +47 23 26 80 20
KUAU@dnb.no


For ADR Holders:
J.P. Morgan Chase
ADR Broker Enquiries
T: +1 212 552 8926
drx_depo@jpmorgan.com